1. Page, R.C., and H. Schroeder. 1982. Periodontitis in man and other animals, a comparative review. Basal: S. Karger.

2. Page, R.C. 1991. The role of inflammatory mediators in the pathogensis of periodontal disease. J. Periodont Res. 26:230-42.

3. Williams R. 1998. Periodontal disease: the emergence of a new paradigm. Compend Contin Educ Dent Supp. 19:4-10.

4. Rose L.R., B.J. Steinberg and L. Minsk. 2000. The relationship between periodontal disease and systemic conditions. Compendium 10: 870-877.

5. Meinig G.E. 1998. Root Canal Cover-up. Ojai, Calif.: Bion Publishing.
6. Glassman G. 1998. Root canal cover-up exposed: the resurgence of the refuted focal infection theory. Oral Health 88 (12): 3.

7. Debelian et al. 1998. Anaerobic bacteremia and fungemia in patients undergoing endodontic therapy: an overview. Ann Periodontogy 3 (1): 281-7.

8. Oral Health in America. A report of the Surgeon General. Executive Summary. Department of Health and Human Services.

9. Golub. 1998. Dentistry Today (Oct).

10. Navazesh M and R Mulligan. 1995. Systemic dissemination as a result of oral infection in individuals 50 years of age and older. Spec. Care Dentist 15 (1): 11-9.

11. Page R.C. and K.S. Kornman. 1997. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14:.9-11.

12. Loe et al. 1986. Natural history of periodontal disease in man: rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J. Clin. Periodontol 13:431-445.

13. Chen I. 2000. The Surgeon General's report on oral health: implications for research and education, NY State Den.t J. 66:.38-42.

14. Lamont R.J. and H.F. Jenkinson. 1998. Life below the gum line: pathogenic mechanism of Porphyromonas Gingivalis. Microbiol. Mo.l Biol. Rev. 62 (4):.1244-63.

15. Debekuan et al. 1994. Systemic diseases caused by oral microorganisms. Endod. Dent. Traumato. 10 (2): 57-65.

16. Beck et al. 1998. Periodontitis: a risk factor for coronary heart disease, Ann. Periodontol. 3 (1): 127-41.

17. Loesche W. 1997. Associations of the oral flora with important medical diseases. Current Opinion Periodontal 4:21-8.

18. Meyer D.H. and P.M. Fives-Taylor. 1998. Oral pathogens: from dental plaque to cardiac disease. Current Opinion Microbiol. 1 (1):88-95.

19. Dorn et al. 1999. Invasion of human coronary artery cells by periodontal pathogens. Infection and Immunity 67 (11): 5792-5798.

20. Emingil G et al. 2000. Association between periodontal disease and acute myocardial infarction. Journal of Periodontology 71 (12): 1882-1886.

21. Iacopino et al. 2000. Pathophysiological relationships between Periodontitis and systemic disease: Recent concepts involving serum lipids, Journal of Periodontology 71 (8): 1375-1384.

22. Haraszthy et al. 1999. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol 2000 71(10): 1554-60.

23. Wu T. 2000. Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. American Journal of Epidemiology 151: 273-282.

24. DeNardin et al. 2000. Fibrinogen linked to gum disease. U. of Buffalo 31 (27).

25. Genco R.J. 1999. Risk factors for periodontal diseases. Periodontal Medicine. Ontario, Canada: BC Decker Publishing.

26. Loesch W.J. 1994. Periodontal disease as a risk factor for heart desease. Compendium 15(8): 976,978-82,985-6 passim; quiz 992.

27. Joshipura K.J. 1996. Poor oral health and coronary heart disease. J. Dent. Res. 75 (9): 1631-6.

28 .Syrjanen et al. 1989. Dental infections in association with cerebral infarction in young and middle-age men. J. Intern. Med. 225(3): 179-84.

29. Beck et al. 1996. Periodontal disease and cardiovascular disease. J. Periodontol. 67 (suppl.1): 1123-37.
30. Ibid.

31. Arbes et al. 1999. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III date J. Dent. Res. 798 (12): 1777-82.

32. Herzberg M.C. and M.W. Meyer. 1996. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J. Periodontol 67 (10 Suppl): 1138-42.

33. Herzberg M.C. and M.W. Meyer. 1998. Dental plaque, platelets and cardiovascular diseases. Ann. Periodontol 3 (1): 151-60.

34. Dorn B.R. et al. 1999. Invasion of human coronary artery cells by periodontal pathogens. Infect. Immun. 67 (11): 5792-5798.

35. Mattila et al. 1993. Dental Infections as a risk factor for acute myocardial infarction. Eur. Heart J. 14 (Suppl K): 51-3.

36. Mattila et al. 1993. Dental infections and coronary atherosclerosis. Atherosclerosis 103 (2):205-11.

37. Mattila et al. 1995. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin. Infect. Dis. 20 (3):588-92.

38. Wu et al. 2000. Periodontal disease and risk of cerebrovascular disease: the First National Health and Nutrition Examination Survey and its follow-up study. Archives of Internal Medicine 18:2749-2755.

39. Grau et al. 1997. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Journal Stroke (9) 1724-9.

40. Grossi et al. 1997. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J. Periodontol 68(8): 713-719.

41. Grossi et al. 1998. Periodontal Disease and Diabetes Mellitius: A two-way relationship. Annals Periodontol 3(1): 51-61.

42. Thorstensson et al. 1996. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J. Clin. Periodontol 23 (3 Pt 1): 194-202.

43. Shlossman et al. 1990. Type 2 diabetes mellitus and periodontal disease. J. Am. Dent. Assoc. 121:532-536.

44. Murayama et al. 2001. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. Journal of Periodontol 72 (6): 774-778.

45. Katz J. 2001. Elevated blood glucose levels in patients with severe periodontal disease. J. Clin. Periodontol 28: 710-12.

46. Nelson et al. 1990. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 13:836-40.

47. Tabaj et al. 2000. Flow cytometry as a new method to study periodontal disease in diabetic patients. Diabetologia Croatica. 29 (1): 27-31.

48. National Diabetes Data Group: Diabetes in America data compiled 1984. 1985. Bethesda, Md. National Institute of Health. Publication No. 851268.

49. Heller et al. The Carbohydrate Addict's Healthy Heart Program. New York: Ballantine Books.

50. Ibid.

51. Grossi et al. 2000. Obesity-gum disease link found. U of Buffalo Reporter 31 (25).

52. Ibid.

53. O'Abay. 1996. Does H. pylori induce gastritis food-stimulated insulin release? Dig. Dis. Sci. 41 (7): 21327-31.
54. Scannapieco F.A., and J.M. Mylotte. 1996. Relationships between periodontal disease and bacterial pneumonia. J. Periodontol 67(10 Suppl): 114-22.

55. Dahlen et al. 1995. Occurrence of enteric rods, staphylococci and Candida in subgingival samples. Oral Microbio.l Immunol.10:42-46.

56. Bentley D.W. 1984. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology and treatment. Gerontol. 30:297-307.

57. Dasanayake A.P. 1998. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann. Periodontol 3 (1):206-12.

58. Davenport et al. 1998. The East London study of maternal chronic periodontal disease and pre-term low birth weight infants: study design and prevalence data. Ann Periodontol 3 (1): 213-21.

59. Offenbacher et al. 1998. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 3(1):233-50.

60. Offenbacher et al. 1996. Periodontal disease as a possible risk factor for pre-term low birth weight. J. Periodontal 67:1103-13.

61. Gibbs et al. 1992. A review of premature birth and subclinical infections. American Journal Obster. Gynecol. 166(5): 1515-1528.

62. Loesche W.J. 1997. Association of the oral flora with important medical diseases. Curr. Opin. Periodontol 4:21-28.

63. Hill G.B. 1998. Preterm birth: associations with genital and possibly oral microflora. Ann. Periodontol. 3(1): 222-32.

64. American Academy of Periodontology" Specialty Conference on Periodontal Medicine, Importance of Good Oral Health in Pregnant Women. 2000. Washington D.C.

65. Collins et al. 1994. Effects of Porphyromonas Gingivalis infection on inflammatory mediator response and pregnancy outcome in hamster. Infect. Immun. 62:4356-4361.

66. Collins et al. 1994. Effects of Escherichia coli and Porphyromonas gingivalis lipopolysaccharide on pregnancy outcome in the golden hamster. Infect. Immun. 62:4652-4655.

67. Tezak et al. 2000. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol. 71(9): 1492-1498.

68. Loomer et al. 1994. Direct effects of metabolic products and sonicated extracts of Porphyromonas Gingivalis 2561 on ostergenesis in vitro. Infect. Immune. 62(4) :1289-97.

69. Wactawski-Wende et al. 1998. Osteoporosis, oral health linked ; Analysis of national database shows strong relationship. American Association for the Advancement of Science.

70. Ebersole J.L. 1990. Systemic humoral immune response in periodontal disease. Crit. Rev. Oral. Biol. Med. 1:283-331.

71. Moore W.E.C., and L.V.H. Moore. 1994.The bacteria of periodontal diseases. Periodontol 2000 5:66-77.
72. Page R.C. 1991.The role of inflammatory mediators in the pathogenesis of periodontal disease. J. Periodont. Res. 26:230-242.

73. Holt S.C., and T.E. Bramanti. 1991. Factors in virulence expression and their role in periodontal disease pathogenesis. Crit. Rev. Oral. Biol. Med. 2:177-281.

74. Haffajee A.D., and S.S. Socransky. 1994. Microbial etiologic agents of destructive periodontal diseases. Periodontol 2000 5:78-111.

75. Lamont R.J., and H.F. Jenkinson. 1998. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Rev. 62(4): 1244-63.

76. Wilson M., and B. Henderson. 1995. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol. Rev. 17:365-379.

77. Fives-Taylor P., D Meyer, and K Mintz. 1995. Characteristics of Actinobacillus actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv. Dent. Res. 9:55-62.

78. Lamont et al. 1995. P. gingivalis invasion of gingival epithehal cells. Infect. Immun. 63:3878-3885.

79. Cugini et al. 2000. The effect of scaling and root planning on the clinical and microbiological parameters of periodontal disease: 12-month results. J. Clin. Periodontol. 27(1): 30-6.

80. Haffajee A.D., and S.S. Socransky. 1994. Microbial etiologic agents of destructive periodontal diseases. Periodontol 2000 5:78-111.

81. Lavine et al. 1979. Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J. Periodont. Res. 14:10-19.

82. Van Dyke et al. 1983. Juvenile periodontitis as a model for neutrophil function: reduced binding of complement chemotactic fragment. J. Den. Res. 62:870-872.

83. Concensus report on Periodontal diseases: pathogenesis and microbial factors. 1996. Ann Periodontol 1: 926-932.

84. Gillespie et al. Isolation and partial characterization of the Campylobacter rectus cytotoxin.

85.Schenkein H.A. 1989. Failure of Bacteroides Gingivalis W83 to accumulate bound C3 following opsonization with serum. J. Periodont. Res. 24:20-27.

86. Culter C.N., R.R. Arnold and H.A. Schenkein 1993. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J. Immunol. 151:7016-7029.

87. Shenker B.J., L.A.Vitale and D.A. Welham. 1990. Immune suppression induced by Actinobacillus actinomycetemcomitans: Effects on immunoglobulin prodection by human B cells. Infect. Immun. 58:3856-3862.

88. Offenbacher S. 1996. Periodontal diseases: Pathogenesis. Ann. Periodontol. 1:821-878.

89. Reynolds J.J., and M.C. Meikle. 1997. Mechanism of connective tissue destruction in periodontitis. Periodontol 2000. 14:144-157.

90. Birkedal-Hansen H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodont Res. 28:500-510.

91. Goldhaber et al. 1973. Bone reabsorption in tissue culture and its relevance to periodontal disease. J. Am. Dent. Assoc. 87:1027-1033.

92. Moore W.E.C., and L.V.H. Moore. 1994. The bacteria of periodontal diseases. Periodontol 2000. 5:66-77.

93. Miyasaki K.T., 1001. The neutrophil: Mechanisms of controlling periodontal bacteria. J. Periodontol. 2:761-774.

94. Ebersole J.L. 1990. Systemic humoral immune responses in periodontal disease. Crit. Rev. Oral. Biol. Med.1:283-331.

95. Llamster I.B. and M.J. Novak. 1992. Host mediators in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. Crit. Rev. Oral. Bio. Med. 3:31-60.

96. Allison et al. 1976. Activation of complement by the alternative pathway as a factor in the pathogenesis of periodontal disease. Lancet 2 (7993):1001-4.

97. Schindler L.W. How the Immune System works. National Institute of Health.

98. Genco et al. 2000. Low Dietary Vitamin C Can Increase Risk for Periodontal disease. J. of Periodontology.

99. Grossi et al. 1999. HNANES III, University of Buffalo Reporter. 30 (24).

100. Mcguire M.K., and M.M. Nunn. 1999. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J. Periodontol 70 (1): 49-56.

101. Komman et al. 1997. The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol 24:72-77.

102. Hart T., and K.S. 1997. Komman. Genetic factors in the pathogensis of periodontitis. Periodontol 2000 14:202-215.

103. World Health Organization: The World Health Report 1995: bridging the gap. Geneva, Switzerland.

104. Gallin J.L. 1988. The neutrophil: Immunological diseases. 4th ed. Boston: Little, Brown.

105. Pisciotta A.V. 1990. Drug-induced agranulocytosis; peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev. 4(4): 226-37.

106. Nery et al. 1995. Prevalence of nifedipine-induced gingival hyperplasis. J. Periodontol. 66:572-578.

107. Tomar S.L., and S. Asma. 2000. Smoking - attributable periodontitis in the United States findings for NHANES III. J. Periodontol 2000. 71:743-751.

108. Gelsky S.C. 1999. Cigarette smoking and periodontitis: Methodology to assess the strength of evidence in support of a causal association. Comm. Dent. Oral. Epidemiol. 27:16-24.

109. Costerton et al. 1994. Biofilms, the customized microniche. J. Bacteriol. 176:2137-2142.

110. Haber J. 1994. Cigarette smoking: a major risk factor for periodontitis. Compend. Contin. Dent. Educ. 15:1002-14.

111. Edwardsson et al. 1999. The microbiota of periodontal pockets with different depths in the therapy-resistant periodontitis. J. Clin. Periodontol. 26(3): 143-52.

112. Tomar S.L., and S. Asma. 2000. Smoking-attributable periodontitis in the United States: findings for NHANES III. J. Periodontol 2000 71:743-751.

113. Ibid.

114. Grossi et al. 2001. Caution: alcohol may be hazardous to your (oral) health. UB Research Quarterly ( Feb).

115. Watson M.R., W.A. Bretz, and W. J. Loesche. 1994. Presence of Treponema denticola and Porphyromonas gingivalis in children correlated with periodontal disease of their parents. Journal of Dental Research. 73(10): 1636-40.

116. Petit et al. 1994. Prevalance of periodontitis and suspected periodontal pathogens in families of adult periodontitis paients. J. Clin. Periodontol. 21: 76-85.

117. van Steenbergen et al. 1993. Transmission of Porphyromonas gingivalis between spouses. J. Clin Periodontol 20:340-5.

118. Preus et al. 1994. The distribution and transmission of Actinobacillus actinomycetemcomitans in families with established adult periodontitis. Journal Periodontol. 65:2-7.

119. Saarela et al. 1993. Transmission of oral bacterial species between spouses. Oral. Microbiol. Immunol. 8:349-54.

120.Asikainen S., C. Chen and J. Slots. 1996. Likelihood of transmitting Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in families with periodontitis. Oral Microbiol Immunol. 11(6): 387-94.

121. Asikainen S., and C. Chen. 1999. Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 2000. 20:65-81.

122. Preus H.R. and L. Olsen. 1988. Possible transmittance of A. actinomycetemcomitans from a dog to a child with rapidly destructive periodontitis. Journal of Periodontal Research 23:68-71.

123. Barker K.F. 1999. Antibiotic resistance: a current perspective. Br. J. Clin. Pharmacol. 48:109-24.

124. Roberts M.C. 1998. Antibiotic resistance in oral/respiratory bacteria. Crit. Rev. Oral. Biol. Med. 9(4): 522-40.

125 Summers et al. 1993. Mercury released from Dental"silver" fillings provokes and increase in mercury-and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob. Agents Chemother. 37(4): 825-34.

126. Lorsheider et al. 1995. The dental amalgam mercury controversy-inorganic mercury and the CNS; genetic linkage of mercury and antibiotic resistances in intestinal bacteria. Toxicology 31(1-3):19-22.

127. Edlund et al. 1996. Resistance of the normal human microflora to mercury and antimicrobials after exposure to mercury from dental amalgam fillings. Clin. Infect. Dis. 22(6): 944-50.

128. Smith A., and J. Bragg. 1998. An update on antimicrobial chemotherapy 3: antimicrobial resistance and the oral cavity. Dental Update. 25:230-4.

129. van Windelhoff A.J. et al. 2000. Antimicrobial resistance in the subfingival microflora in patients with adult periodontitis: a comparison between the Netherlands and Spain. J Clin Periodontol 27 (2)79-86.

130. Fives-Taylor P.M. et al. 1999. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 20:136-67.

131. Larsen T. 1991. Occurrence of doxycycline-resistant bacteria in the oral cavity after administration of doxycycline in patients with periodontal disease. Scand J Infect Dis. 23:89-96.

132. Ibid.

133. Rosenberg J. 2000. Antibiotic resistance: what physicians should know. Division of Communicable Disease Control: California Department of Health Services January.

134. Ballow C. 1998. Antibiotics vs. infectious bacteria: a battlefield report. U. of Buffalo Reporter 29 (21) February.

135. Williams D. 2000. A new edge in the race against thoroughbred bugs. Alternatives. Vol.8. no.17 Nov.

136. Ballow C. 1998. Antibiotics vs. infectious bacteria: a battlefield report. U. of Buffalo Reporter 29 ( 21) February.

137. Levy S.B. 1992. The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle. New York: Plenum Publishing.

138 . Walker CB. 1996. The acquisition of antibiotic resistance in periodontal microflora. Periodontol 2000. 10:79-88.

139. Baker P. et al. 1995. Antibiotic susceptibility of anaerobic bacteria from the human cavity. J Dent Res. 64:1233-44.

140. Walker C.B. et al. 1983. Antibody susceptibility testing of subgingival plaque samples. J Clin Periodontol 10:422-432.

141. Lewis M.A. et al. 1995. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J Antimicrob Chemother. 35:785-91.

142. Sorsa T. et al. 1992. Cellular source and tetracycline inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 19 (2):146-149.

143. Grant D, Infectious Disease and Super Germs.

144. Strom B.L. et al. 1998. Dental and cardiac risk factors for infective endocarditis: a population-based-control study. Ann Intern Med. 129:761-9.

145. Durack DT et al. 1983. Apparent failures of endocarditis prophylaxis. JAMA 250:2318-22.

146. American Academy of Periodontology. 1996. Systemic antibiotics in periodontics (position paper). J Periodontol. 67:831-8.

147. Ewald P. 2000. Plaque Time. New York: The Free Press.

148.Wilson TG Jr. 1996. Supportative periodontal treatment introduction: definition, extent of need, therapeutic objectives, frequency and efficacy. Periodontol 2000 12:11-15.

149. Lamster IB. 2001. Current Concepts and Future Trends for Periodontal Disease and Periodontal Therapy, Part 2. Dentistry Today. 3:88.

150. Estafen et al. 1999. Adjunctive diagnostic methods for monitoring progressive periodontal diseases. Gen Dent. 47 (4):374-80.

151. Mancina S. et al. 1999. Assessment of a novel screening test for Neutrophil collagenase activity in the diagnosis of periodontal diseases. J Periodontol. 70 (11):1292-302.

152. Slots J. 1996. Microbial analysis in supportive periodontal therapy. Periodontol 2000. 12:56-9.

153. Loesche W. et al. 1992. Comparison of the benzoyl-DL-arginine-naphthylamide (BANA) test, DNA probes, and immunologicalreagents for ability to detect anaerobic periodontal infections due to Porphyroomonas gingivalis,Treponema denticola and Bacteroides forsythus. J Clin Microbiol. 30:427-433.

154. Loesche W. et al. 1997. The optimization of the BANA test as a screening agent for gingivitis among subjects seeking dental treatment. J Clin Perio. 4:114.

155. Lindhe J. et al. 1982. Critical probing depths in periodontal therapy. J Clin Periodontol. 9(4): 323-36.

156. Riffle A.B. 1952. The cementum during curettage. J Periodontol. 23:170-177.

157. BBC Homepage. 2001. Health news. Thursday, 26 July.

158. Dyer D, Addy M, Newcombe RG. 2000. Studies in vitro of abrasion by different manual toothbrush heads and a standard toothpaste. J Clin Periodontol. 27 (2) 99-103.

159. Warren D. et al. 2001. The effects of toothpastes on the residual microbial contamination of toothbrushes. Journal of the American Dental 9:1241-1245.

160. Cobb CM. 1920. Toothbrushes as a cause of repeated infections of the mouth. Boston Medical Surgery Journal 183:263-4.

161. Glass R.T. and S. Shapiro. 1993. Oral inflammatory disease and the toothbrush. J Ala Dent Assoc. 77(4): 12-6.

162. Glass R.T. 1992. The infected toothbrush, the infected denture and transmission of disease: a review. Compendium 13(7): 592-8.

163. Svanberg M. 1978. Contamination of toothpaste and toothbrush by Streptococcus mutans. Scand J Dent Res 86:412-4.

164. Kozai K., T Iwai and D Miura. 1989. Residual contamination of toothbrushes by microorganisms. ASDC J Dent Child. 56: 201-4.

165. Caudry SD, A Klitorinos and EC Chan. 1995. Contaminated toothbrushes and their disinfection. J Can Dent Assoc 61(6): 511-6.

166. Glass RT and HG Jensen. 1994. The effectiveness of a u-v toothbrush sanitizing device in reducing the number of bacteria, yeasts and viruses on toothbrushes. J Okla Dent Assoc 84(4):24-8.

167. Glass RT and HG Jensen. 1988. More on the contaminated toothbrush: the viral story. Quintessence Int 19:713-6.

168. Warren DP et al. 2001. The effects of toothpastes on the residual microbial contamination of toothbrushes. JADA 132:1241-5.

169. Yukna R.A. et al. 1993. Interproximal vs midradicular effects of a counter-rotational powered brush during supportive periodontal therapy. Compendium 16: S580-6.

170. Yuka RA, et al. 1993. Evaluation of counter-rotational powered brush in patients in supportive periodontal therapy. J Periodontal 64:859-64.

171. Stanford CM et al. 1997. Efficacy of the Sonicare toothbrush fluid dynamic action on removal of human supraginigival plaque J Clin Dent. Special issue: 10-4.

172. Otomo-Corgel J. 1992. Over-the-counter and prescription mouthwashes - an update for the 1990's. Compendium of Continuing Dental Education in Dentistry 13:1086-1095.

173. Lamberts DM et al. 1982. The effect of waxed and unwaxed dental floss on gingival response. J Periodontol 53: 393-6.

174. Wunderlich RC et al. 1982. The effect of waxed and unwaxed dental floss on gingival response. J Periodontol 53: 397-400.

175. Gross A. et al. 1975. Effects of tongue brushing on tongue coating and dental plaque scores. J Dent Res. 54:1236.

176. Christen AG et al. 1978. Oral hygiene: a history of tongue scraping and brushing. JADA 96: 215-9.

177. Wunderlick RC et al. 1984. Subgingival penetration of an applied solution. Int J Perio Restorative Dent. 4 (5): 64-71.

178. Waerhaug J. 1981. Effect of tooth brushing on subgingival plaque formation. J Periodontol. 52(1): 30-4.

179. The role of supra and subgingival irrigation in the treatment of periodontal diseases. 1996. Chicago: American Academy of Periodontics 1-18.

180. Eakle WS, C Ford and RL Boyd. 1986. Depth of penetration in periodontal pockets with oral irrigation. J Clin Periodontal 13(1): 39-44.

181. Larner JR and G Greenstein. 1993. Effect of calculus and irrigation tip design on depth of subgingival irrigation. Int. J Periodontics Restorative Dent. 13(3): 288-97.

182. Braun RE and SG Chancio. 1992. Subgingival delivery by an oral irrigation device. J Periodontal. 63: 469-72.

183.Newman et al. 1994. Effectiveness of Adjunctive Irrigation in Early Periodontitis: Multi-Center Evaluation. J Periodontal 65:224-229.

184. Nelson S. 2000. Sodium bicarbonate inhibits plaque formation on teeth. Dentist. 68: 23-38.

185. Legier-Vargas et al. 1995. Effects of sodium bicarbonate dentifrices on the levels of bacteria in human saliva. Caries Res. 29: 143-147.

186. Tanzer et al. Bicarbonate-based powder and paste dentifrice effects on caries. Clin Prev Den. 12: 18-21.

187. Koertge et al.1998. Longitudinal comparison of tooth whitening resulting from dentifrice use. J Clin Dent. 9:67-71.

188. Ody P. 2000. Natural Health, Complete Guide to Medicinal Herbs. New York: Darling Kindersley.

189. Graedon et al. 1999. The People's Pharmacy Guide to Home and Herbal Remedies. New York: St. Martin's Griffin.

190. Hildebrandt GH and BS Sparks. 2000. Maintaining mutans streptococci suppression with xylitol chewing gum. J Am Dent Assoc. 131: 909-916.

191. Vogel et al. 1978. The effect of folic acid on gingival health, J Periodontol 47(11): 667-668.

192. Caranza F. 1984. Clinical Periodontology. Philadelphia: WB Saunders.

193. Packer L. 2000. Alpha Lipoic Acid as a biological antioxidant, Free Radical Biology and Medicine.

194. Weyers W. et al. 1989.Skin absorption of volatile oils, Pharmacokinetics Pharm Unsrer Seit 18: (3):82-6.

195. Sinatra S. 1999. L-Carnitine and the Heart, How the powerful combination of L-caritine and CoQ10 can have a positive impact on one's health and well-being. Los Angles: Keats Publishing.

196. da Costa et al. 1974. Appearance of folate binder in leukocytes and serum of women who are pregnant or taking oral contraceptives. J Lab Clin Med 83:207-214.

197. Vogel et al. 1976. The effect of folic acid on gingival health. J Periodontol 47(11):667-668.

198. Vogel et al. 1979. The effect of topical application of folic acid on gingival health. J Oral Med 33 (1):20-2.

199. Thompson et al. 1982. Effects of extended systemic and topical folate supplementation on gingivitis of pregnancy. J Clin Periodontol ((9):275-80.

200. Pack et al. 1980. Effects of topical and systemic folic acid supplementation on gingivitis in pregnancy. J Clin Periodontol 7(5): 402-414.

201. Pack et al. 1984. Folate mouthwash: effects on established gingivitis in periodontal patients. J Clin Periodontol 11(9) :619-628.

202. Vogel et al. 1976. The effect of folic acid on gingival health. J Periodontol 47(11):667-668.

203. Adhikari et al. 2001. Free radical scavenging behavior of folic acid: Evidence for possible antioxidant activity. Free Radical Biology & Medicine. 30 (12): 1390-1399.

204. Cohen et al. 1986. Safety of pyridoxine-A review of human and animal studies. Toxicol Letters 34: 129-139.

205.Mason et al. 1992. The effects of vitamins B12, B6 and folate on blood homocysteine levels. Ann NY Acad Sci. 669:197-203.

206. Lubec et al. 1996. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocysteine. Biochim Biophys Acta 1315(3):159-162.

207. Brattstrom et al. 1985. Folic acid responsive postmenopausal homocysteinemia. Metabolism 34 (11): 1073-1077.

208. Wilcken et al. 1985. Homocystinuria due to cystathionine beta-synthase deficiency-the effects of betaine treatment in pyridoxine-responsive patients, Metabolism 34 ((12):115-1121.

209. Dorman H. 2000. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J of Applied Microbiology, 88 (2): 308-316.

210. Badmaev et al. 1996. Comparison of nutrient bioavailability when ingested alone and in combination with Bioperine, Research Report, Sabinsa Corporation.

211. Ibid.

212. Clark H, 1993. The Cure for All Cancers. San Dieo: ProMotion Publishing.

213. Godowski KC. 1989. Antimicrobial action of sanguinarine, J Clin Dent 1: 96-101.

214. Nielson FH. 1990. Studies on the relationship between boron and magnesium, which possibly effect the formation and maintenance of bones. Magnesium Trace Elem 9:61-69.

215. Frei et al. 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci 86: 66377-81.

216. Nakamoto et al. The role of ascorbic acid deficiency in human gingivitis-a new hypothesis. J Theor Biol 108 (2):163-171.

217. Goetzl et al. 1974. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest 53 : 813.

218. Thomas et al. 1978. Vitamin C and immunity: an assessment of the evidence. Clin Exptl Immunol 32: 370.

219. Rivers JM. 1989. Safety of high level vitamin C ingestion. Int J Vit Ntr Res 30 (Suppl): 95-102.

220. Abraham et al. 1990. Total dietary program emphasizing magnesium instead of calcium. J Repro Med 35 (5): 503-507.

221. Abraham GE. 1982. The calcium controversy. J Appl Nutr 34: 69.

222. Bourgoin et al. 1993. Lead Content in 70 Brands of Dietary Calcium Supplements. Am J Public Health 83 :1155-60.

223. Hoffman D. 1983. The Holistic Herbal. Scotland: Findhorn Press, Scotland 1983.

224. Haines CE. 1994. Antimutagenesis and Lethality Studies of Cinnamaldehyde in Bacterial Systems. University of Kansas. 56 (04B).

225. Tantaoui-Elaraki et al. 1994. Inhibition of growth and aflatoxin production in Aspergillus parasiticus by essential oils of selected plant materials. J Environ Pathol Toxicol Oncol 13 (1):67-72.

226. Goldenberg R. 1997. Drug and Cosmetic Industry. 06.

227. Inouye et al. 1998. Antisporulating and respiration-inhibitory effects of essential oils on filamentous fungi. Mycose 41 (9-10): 403-10.

228. Jayashree et al. 1999. Anti-aflatoxigenic activity of eugenol is due to inhibition of lipid peroxidation. Lett Appl Microbiol. 28(3):179-83.

229. Wie et al. 1997. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci Lett, 4 ;225(2):93-96.

230. Siddiqui et al. 1996. Effect of essential oils on the enveloped viruses : Antiviral activity of oregano and clove oils on herpes simplex virus type 1 and Newcastle disease virus. Medical Science Research 24 (3):185-186.

231. Hansen et al. 1976. Bioenergetics in clinical therapy. Gingival and leucocytic deficiencies of coenzyme Q10 in patients with periodontal disease. Res Commun Chem Pathol Pharmacol 14(4): 729-738.

232. Matsumura et al. 1973. Evidence for enhanced treatment of periodontal disease by therapy with coenzyme Q. Int J Vitam Nutr Res 43 (4):537-548.

233. Nakamura et al. 1974. Study of coenzyme Q in gingival of patients with periodontal disease and evidence for a deficiency of coenzyme Q10. Proc Natt Acad Sci 71:1456.

234. Batino et al. 1999. Oxidative injury and inflammatory diseases: the challenge of antioxidants to free radicals and reactive oxygen speies. Crit Rev Oral Biol Med 10(4): 458-76.

235. Folkers et al. 1981. Biomedical and Clinical Aspects of Coenzyme Q. vol. 3, Amsterdam: Elsevier/North Holland Biomedical Press.

236. Wilkinson et al. 1977. Treatment of periodontal and other soft tissue diseases of the oral cavity with coenzyme Q. In Biomedical and Clinical Aspects of Coenzyme Q administration. Vol. 1 Folkers K and Yamamura Y (eds.) Elsevier/North-Hollarn Biomedical Press, Amsterdam.

237. Hanioka et al. 1994. Effect of topical application of coenzyme Q10 on adult Periodontitis. Mol Aspects Med 15 Suppl: 241-248.

238. Emile etal. 1987. The Miracle Nutrient CoEnzymeQ10. New York: Bantam Books.

239. Lewis AJ. 1984. The role of Copper in Inflammatory Disorders. Agents Actions.

240. Airola P. 1976. How to Get Well. Health. Phoenix: Plus Publishers.

241. Kim et al. 1983. The effect of Vitamin E on the Healing of Gingival Wounds in rats. J Periodontal 54:305-8.

242. Royack et al. 2000. Response of human oral epithelial cells to oxidative damage and the effect of vitamin E. Oral Oncology 36(1):37-41.

243. Addya et al. 1984. Effects of Mercuric Chloride on Several Scavenging Enzymes in Rat Kidney and Influence of Vitamin E Supplementation. Acta Vitaminol Encymol 6;103-107.

244. Courtney et al. 1991. Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells. Infect Immun. 59(5): 1661-1666.

245. D'Amelio F. 1999. Botanicals, A Phytocosmetic Desk Reference. Boca Raton: CRC Press.

246. Wagner et al. 1989. In vitro inhibition of arachidonate metabolism by some alkylamides and phenylated phenols. Planta Medica. 55:566-567.

247. Wagner et al. 1985. Immunostimulating polysaccharides (heteroglycans) of higher plants. Arzneimittel-Forsch 35: 1069-75.

248. Hobbs C. 1989. The Echinacea Handbook. Portland: Eclectic Medical Publications.

249. Bauer et al. 1991. Echinacea species as potential immunostimulatory drugs. Econ Med Plant Res 5: 253-321.

250. D'Amelio F. 1999. Botanicals, A Phytocosmetic Desk Reference. Boca Raton: CRC Press.

251. Weyer et al. 1989. Skin absorption of volatile oils. Pharmacoinetics. Pharm Unsrer Seit 18 (3): 82-86.

252. D'Amelio F. 1999. Botanicals, A Phytocosmetic Desk Reference. Boca Raton: CRC Press.

253. Boiteau et al. 1956. Asiaticoside. Extracted from Centella asistica. Its therapeutic uses in the healing of experimental or refractory wounds, leprosy, skin tuberculosis and lupus. Therapie 11: 125-149.

254. Tenni et al. 1988. Effect of the triterpenoid fraction of Centella Asiatica: on macromolecules of the connective matrix in human skin fibroblast cultures. Ital J Biochem 37:69-77.

255. Shukla et al. 1999. Asiaticoside induced elevation of antioxidant levels in healing wounds. Phytother Res 13:50-54.

256. Suguna L. 1996. Effects of Centella asiatica extract on dermal wound healing in rats. Indian J Exp Biol 34 (12):1208-11.

257. Antibiotic Alternative Proven Effective, The GSE Report 1:1, 1.

258. Masquelier J. 1990. Procyanidolic oligomers. J Parfums Cosmet Arom. 95:89-97.

259. Laparra J. 1978. Parmacokinetic study of the total procyanidolic oligomers of the grape. Acta Therapeutica. 4: 233-246.

260. Hagerman et al. 1981. The specificity of Proanthocyanidin-Protein interactions. Journ of Biol Chemistry 256: 4494-4497.

261. Sorsa et al. 1990. The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. Arch Oral Biol Supp. 35: 193-196.

262. Nakamura M. 1979. The relationship between periodontal disease and protease activity in gingival fluid and in saliva. Nippon Shishubyo Gakkai Kaishi. 21(4): 429-434.

263. Inoue J. 1990. Distribution of enzymatically pathogenic bacteria from periodontal pocket in advancing periodontitis. Nippon Shishubyo Gakkai Kaishi. 32(1): 199-205.

264. Bombardelli et al. 1996. Aesculus hipposcastanu. Fitoterapia Vol LXVII (6): 503.

265. Gilman et al. 1980. The Pharmacological Basis of Therapeutics, 6th edition.

266. Reimann et al. 1977. Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formation by (+)- catechin, an inhibitor of specific histidine decarboxylase in vitro. Agents Actions 7(1): 69-73.

267. Amelia et al. 1985. Inhibition of mast cell histamine release by flavonoids and bioflavonoids. Planta Medica 5116-20.

268. Uchida et al. 1987. Condensed tannins scavage active oxygen radicals. Med Sci Res. 15: 831-832.

269. Montogomery et al. 1993. Biochemistry. 4th edition. St. Louis: Mosby Company.

270. Price PA. 1993. Vitamin K nutrition and postmenopausal osteoporosis. J Clin Invest 91(4):1268.

271. Lorrondo et al. 1995. Antimicrobial activity of essences from labiates. Microbios 82 (332): 171-2.

272. Combest WL. 1999. Lavender. US Pharmacist (USA) 24: 30-33.

273. Petrovski S. 1888. Study of the antibacterial and antimycotic action of lavender essential oil. Dermatol Veneral. 27 (3):46-50.

274. Perrucci et al. 1994. Acaricidal agents of natural origin against Psoroptes cuniculi. Parassitologia 36(3): 269-271.

275. Nelson R. 1997. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcu faecium. Journal of Antimicrobial Chemotherapy 40 (2): 305-306.

276. Almer et al. 1992. Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. Journal of Clinical Pharmacology 32: 49-54.

277. Astedt et al. 1977. Arrest of growth of ovarian tumour by ranexamic acid. Journal of the American Medical Assoc. 238: 154-155.

278. Rath M. 1992. Plasmin induced proteolysis and the role of apoprotein(a), lysine and synthetic lysine analogs. Journal of Orthomolecular Medicine 7:17-23.

279. Rath M. 2001. Cellular Health Series: The Heart. Santa Clara, Calif. MR Publishing, Inc.

280. Sigurdsson et al. Tranexamic acid for the treatment of advanced ovarian carcinoma. Acta Obstetriticia et Gynecologica Scandinavica 62: 265-266.

281. Balch, P., and J. Balch. 2000. Prescription for Nutritional Healing. New York: Penguin Putnam, Inc.

282. Birkmayer JGD, Biological and Clinical Relevance of Trace Elements. Arztl Lab 36: 284-87, 1990.

283. Balch et al. 2000. Prescription for Nutritional Healing, 3rd ed. New York: Avery Publishing.

284. Tranter HS. 1993. The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. Journal of Applied Bacteriology 74 (3): 253-259.

285. Fleming HP. 1973. Antimicrobial properties of oleuropein and products of its hydrolysis from green olives. Applied Microbiology 26 (5): 777-782.

286. Petkov et al. 1972. Pharmacological analysis of iridoid oleuropein. Drug Res. 22 (9): 1476-86.

287. Walker M. 1997. Nature's Antibiotic Olive Leaf Extract, Kensington Books, Kensington Publishing Corp.

288. Tassou C. 1991. Effect of phenolic compounds and oleuropein on the germination of Bacullus cereus T spores. Biotechnology and Applied Biochemistry 13:231-237.

289. Stiles et al. 1995. The inhibition of Candida Albicans by oregano. J Applied Nutr 47: 96-102.

290. Draughon et al. 2001. Antimicrobial activity of essential oils from plants against selected pathogenic and saprophytic microorganisms. Journal of Food Protection 42 (7): 1019-24.

291. Baratta MT. 1998. Chemical composition, antimicrobial and antioxidative activity of laurel, sage. Rosemary, oregano and coriander essential oils. Journal of Essential Oil Research. 10 (6): 618-627.

292. Sivropoulou A. 1996. Antimicrobial and cytotoxic activities of Origanum essential oils. J. Agric Food Chem. 5: 1202-1205.

293. Kivanc M. Inhibitory and stimulatory effects of cumin, oregano and their essential oils on growth and acid production of Lactobacillus plantarum.

294. Daouk et al. 1995. Antifungal activity of the essential oil of Origanum syriacum L. Journal of Food Protection .58 (10).

295. Siddiqui et al. 1996. Effect of essential oils on the enveloped viruses : Antiviral activity of oregano and clove oils on herpes simplex virus type 1 and Newcastle disease virus. Medical Science Research 24 (3): 185-186.

296. Hammer et al. 1999. Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology. 86 (6): 985-990.

297. Samman et al. 1998. Mint prevents carcinogenesis in hamster cheek pouch. 19 (10): 1795-801.

298. May et al. 1996. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneim Forsch 46:1149-53.

299. Hassanein et al. 1997. Antibacterial action of carvone and some plant extracts on certain phytopathogenic bacteria and pathogenicity of Agro bacterium tumefaciens. Alexandria Journal of Agricultural Research 42;1: 127-136.

300. Yu et al. 1994. Phytotherapy Res. 8(7) : 436.

301. Lee et al. 1988. Mutat Res. 204 (2) : 229.

302. Lin et al. 1973. Microbiol. 6: 97.

303. Jacobs et al. U.S. Patent No. 4,745,104 (May 17,1988 and No. 4, 849,410 (July 18,1989).

304. Howell E. 1985. Enzyme Nutrition. Wayne, New Jersey: Avery Publishing Group.

305. Hoffman D. 1983. The Holistic Herbal. Scotland: Findhorn Press..

306. Rath M. 2001. Cellular Health Series: Cancer. California: MR Publishing.

307. Pearce et al. 1984. Mucosal Mast Cells III: Effect of Quercetin and Other Flavonoids on Antigen-Induced Histamine Secretion from Rat Intestinal Mast Cells. J Allergy Clin Immunol 73:819-23.

308. Busse et al. 1984. Flavonoid Modulation of Human Neutrophil Function. J Allergy Clin Immunol 73: 801-9.

309. Yoshimoto T. 1983. Flavonoids: Potent inhibitors of Archidonate 5-Lipoxygenase. Biochem Biophys Res Comm 116:612-18.

310. D'Amelio F. 1999. Botanicals, A Phytocosmetic Desk Reference. Boca Raton: CRC Press.

311. Roy M. 1994. Supplementation with Selenium and Human Imune Cell Functions II: Effect on Lymphocytes Proliferation and Interleudin 2 Receptor Expression. Biol Trace Elem Res 41:103-14.

312. Kiremidjian-Schumacher et al. 1994. Supplementation with Selenium and Human Immune Cell Functions II: Effect on Cytotoxic Lymphocytes and Natural Killer Cells. Biol Trace Elem Res 41:115-27.

313. Carlisle EM. 1982. The Nutritional Essentiality of Silicon. Nutr Rev 40 (7): 193-198.

314. Fessenden et al. 1987. JS, The Biological Properties of Silicon Compounds. Adv Drug Res. 4:95.

315. Ultee et al. 1999. Bactericidal activity of carvacrol towards the food-borne pathogen Bacillus cereus. 85 (2): 211-218.

316. Lisin et al. 1999. Antimicrobial activity of some essential oils. Acta Horticulrurae (501): 283-288.

317. Marino et al. 1999. Antimicrobial activity of the essential oils of Thymus vulgaris L. measured using a bioimpedometric method. J Food Prot. 62 ( 9): 1017-23.

318. Juven et al. 1994. Factors that interact with the antibacterial action of thyme essential oil and its active constituents. J Appl Bacteriol 76 (6):626-31.

319. Tzakou et al. 1998. Chemical composition and antibacterial properties of Thymus longicaulis subsp.chaoubardii oils: three chemotypes in the same population. Journal of Essential Oil Research 10 (1): 97-99.

320. Hassanein et al. 1997. Antibacterial action of carvone and some plant extracts on certain phytopathogenic bacteria and pathogenicity of Agrobacterium tumefaciens. Alexandria Journal of Agricultural Research. 42 (1): 127-136.

321. Lattaoui et al. 1994. Comparative kinetics of microbial destruction by the essential oils of Thymus broussonettii, T. zygis and T. satureioides. Journal of Essential Oil Research 6 (2): 106-171.

322. Panizzi et al. 1993. Composition and antimicrobial properties of essential oils of four Mediterranean Lamiaceae. J Ethnopharmacol. 39 (3): 167-70.

323. Hildebrandt et al. 2000. Maintaining mutans streptococci suppression with xylitol chewing gum. J Am Dent Assoc. 131: 909-916.

324. Prasad A. 1983. Clinical Biochemical and Nutritional Spectrum of Zinc Deficiency in Human Subjects: An Update. Nutr Rev. 41: 197-208.

325. Freeland et al. 1976. Relationship of Mineral Status and Intake to Periodontal Disease. Am J Clin Nutr 29: 745-9